目的 探讨妊娠糖尿病(gestational diabetes mellitus,GDM)患者应用维生素D3后,对体内炎性因子水平及胰岛素抵抗的影响。方法 选择我院GDM患者60例,随机等量分为对照组(基础治疗)30例,观察组(基础治疗加维生素D3)30例。观察组在对照组治疗基础上给予口服维生素D3 1000 U/d,疗程4周,比较2组治疗前后高敏C反应蛋白(high-sensitivity c-reactive protein,Hs-CRP)、肿瘤坏死因子α(tumor necrosis factor alpha,TNF-α)及胰岛素抵抗变化。结果 观察组治疗后hs-CRP较对照组明显降低[(3.80±1.60) mg/L vs (5.05±1.90) mg/L],差异有统计学意义(P<0.05)。观察组治疗后TNF-α较对照组明显降低[(27.45±5.01) pg/ml vs (35.35±14.50) pg/ml],差异有统计学意义(P<0.05)。治疗后观察组胰岛素抵抗较对照组改善明显,差异有统计学意义(P<0.05)。结论 较高的血维生素D3水平可能通过增加胰岛素敏感性,改善妊娠期糖代谢。
Abstract
Objective To explore the effect of Vitamin D3 in gestational diabetes inflammation factor. Methods Sixty patients with gestational diabetes were randomly divided into two groups:30 cases of control group (treatment group), 30 cases of observation group (foundation treatment group plus vitamin D3). On the basis of the control group, treatment observation group was given oral vitamin D3 1000 U/d for 4 weeks. Before and after treatment, high-sensitivity c-reactive protein (Hs-CRP), tumor necrosis factor alpha and insulin resistance were compared between two groups. Results Before and after treatment ,observation group hs-CRP (mg/L) was decreased obviously, respectively 6.18±2.99,3.80±1.60; control group was 5.78±2.24, 5.05±1.90. There was statistically significant difference (P<0.05). Before and after treatment ,observation group TNF-α(pg/ml) was decreased obviously, respectively 36.33±5.45,27.45±5.01;control group was 40.25±19.25,35.35±14.50. There was statistically significant difference (P<0.05).After treatment, insulin resistance of observation group was improved (P<0.05). Conclusions High Vitamin D3 level in blood can improve glucose metabolism during pregnancy through increasing insulin sensitivity.
关键词
妊娠糖尿病 /
高敏C反应蛋白 /
肿瘤坏死因子α /
胰岛素抵抗
Key words
gestational diabetes mellitus /
hs-CRP /
TNF-α /
insulin resistance
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 张 娅,徐先明.妊娠期糖尿病病因学研究进展[J].中国实用妇科与产科杂志, 2013, 29(4):299-301.
[2] 谢则金,王厚照,黄 璐,等.妊娠糖尿病患者C-P, HbAlc和hs-CRP的改变及意义[J].中国优生与遗传杂志,2011,19(5):75-76.
[3] 周建烈.补充较大剂量维生素D的营养风险与健康效果的研究进展[J].卫生研究,2013,42(1):155-161.
[4] Matarese G, Procaccini C, De Rosa V. At the crossroad of T cells, adipose tissue, and diabetes [J]. Immunol Rev, 2012, 249(1):116-134.
[5] 甘福生.CRP检测在2型糖尿病监控中的应用[J].实验与检验医学,2012,30(2):194-195.
[6] 刘 陶,房 臻,杨 冬,等.炎性及脂肪细胞因子与妊娠期糖尿病发病的相关性及在产褥期的变化[J].中华妇产科杂志,2012,47(6):436-439.
[7] Salmi A A, Zaki N M, Zakaria R, et al. Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus[J]. Vasa,2012,41(2):96-104.
[8] Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases[J]. Autoimmun Rev, 2011,11(2):84-87.
[9] Zhang C, Qiu C, Hu F B, et al. Maternal plasma 25-hydroxyvitamin D concentration and the risk for gestational diabetes mellitus[J].PLoS One, 2008, 3(11):1-6.
[10] Nazarian S, St Peter J V, Boston R C, et al. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose[J].Transl Res,2011,158(5):276-281.
基金
河北省秦皇岛市科技支撑计划项目(201302A089)
PDF(581 KB)
